New York Attorney General Letitia James, the FTC, and six other state attorneys general asked a federal court to hold Martin Shkreli in contempt for allegedly trading pharmaceutical stocks and discussing pharmaceutical companies in violation of his lifetime industry ban. The requested sanctions include divestiture, an accounting of his trading, forfeiture of trading profits, and possible further fines or incarceration; the release describes a request to the court, not a new ruling imposing those measures.
The coalition asked the court to appoint an auditor at Shkreli’s expense, order him to divest pharmaceutical stocks, impose a fine equal to his trading profits since February 4, 2022, plus interest, and impose further fines or possible incarceration for noncompliance. These are requested remedies, not remedies reported as imposed in this release.
This release concerns alleged antitrust violations and a court-ordered pharmaceutical-industry ban, not a privacy enforcement action, so it does not provide a basis for changing data-processing, privacy-notice, consent, or breach-notification clauses. For pharmaceutical vendor, collaboration, and investment agreements, review antitrust compliance representations and covenants, restrictions on competitor communications and market-sensitive public statements, disclosures of ownership interests or securities trading, audit and accounting cooperation, and records-preservation obligations. Employee agreements or policies for personnel subject to industry restrictions should also be checked for applicable trading and communications controls.
Entity
Martin Shkreli
Industry
HealthcareOfficial Press Release
https://ag.ny.gov/press-release/2026/attorney-general-james-urges-court-punish-martin-shkreli-brazenly-violating
federal trade commission et al v martin shkreli memorandum 2
https://ag.ny.gov/sites/default/files/court-filings/federal-trade-commission-et-al-v-martin-shkreli-memorandum-2026.pdf
New York Attorney General Enforcement Page
https://ag.ny.gov/press-releases
"hold Martin Shkreli in contempt and impose significant penalties for violating a lifetime ban from the pharmaceutical industry"
"October 13, 2026"
"the court found Shkreli violated antitrust laws"
"Shkreli has openly traded pharmaceutical stocks and publicly discussed the industry at length"
"Ordering Shkreli to divest all pharmaceutical company stocks;"
$35.0M
New York Attorney General Letitia James announced a settlement with former Celsius CEO Alex Mashinsky over allegations that he misled investors about Celsius’s safety, users, and investment strategies, and failed to register as required under New York law. The settlement permanently bars Mashinsky from the securities, commodities, and cryptocurrency industries and provides for up to $35 million in payments to New York under specified conditions.
New York Attorney General Letitia James and a multistate coalition sued the U.S. Department of Labor, alleging it unlawfully canceled grants for state unemployment insurance system upgrades after approving the states’ plans. The coalition seeks restoration of the remaining funding and damages; the release does not report a court ruling or penalty.
$1.1M
New York and a coalition of 47 other attorneys general secured settlements with Ascend Laboratories and Mayne Pharma over an alleged scheme to inflate generic drug prices and reduce competition. Mayne agreed to pay $650,000 and Ascend $400,000, with settlement funds distributed to impacted consumers and the companies agreeing to internal antitrust reforms.
New York Attorney General Letitia James joined a 15-state coalition in suing HHS Secretary Robert F. Kennedy, Jr., challenging changes that removed seven vaccines from the CDC’s list of vaccinations recommended for every child. The states allege the changes and ACIP appointments violated the Administrative Procedure Act and ask the court to invalidate them; the release reports no penalty or court-ordered remedy.
New York Attorney General Letitia James joined a coalition lawsuit challenging NHTSA’s rollback of federal fuel economy standards. The coalition alleges that the final rule violates federal law and asks the court to strike it down; the press release describes no privacy violations or monetary penalty.
$400.0M
New York Attorney General Letitia James and a coalition of 47 other attorneys general secured a $400 million settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc. over an alleged scheme to coordinate generic drug prices and reduce competition. The settlement provides for consumer compensation and requires Sandoz to implement antitrust compliance reforms, including annual staff training and a Chief Compliance Officer.